New Oct. 17, 2026 (Saturday Only)
2026 Nuclear Pharmacy Conference
(6 hrs. CPE)

Home New Oct. 17, 2026 (Saturday Only)
2026 Nuclear Pharmacy Conference
(6 hrs. CPE)

New Oct. 17, 2026 (Saturday Only)
2026 Nuclear Pharmacy Conference
(6 hrs. CPE)

$150.00

ACCREDITATION

iCARE Pharmacy Services, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an ACPE application-based* and knowledge-based activity. Participants may receive up to 6 hours of CPE credit by attending sessions and successfully completing the CPE activity evaluation.

iCARE Pharmacy Services, Inc. is approved by the Florida Board of Pharmacy as a provider of continuing pharmacy education.

 

DISCLOSURES

Speakers have no relevant conflict of interests nor financial relationships.  All persons in a position to control the content of this activity have declared that no conflict of interest exists for this activity.

TARGET AUDIENCE
Nuclear Pharmacists and any pharmacist interested in nuclear pharmacy education.

CANCELLATION POLICY
Participants must submit cancellations in writing. Participants will receive a credit for a future CPE program.

ZOOM WEBINAR INFORMATION
Participants may join via any electronic device. Be sure to have downloaded the ZOOM software in advance to avoid any delays. You will be able to see the speakers and their presentations. You will be able to respond to speaker learning assessments via the CHAT Feature and ask questions via the Q&A Feature.

 

Required Computer Hardware/Software

Please ensure your computer system meets the following minimum requirements:

Zoom system requirements: Virtual Desktop Infrastructure (VDI)

  • Broadband internet connection: cable, high-speed DSL and any other medium that is internet accessible
  • Internet Browser (MAC and/or Windows) – Internet Explorer, Google Chrome, Firefox, Safari
  • Media Requirements – Microsoft PowerPoint, Adobe reader

 

 

 

 

 

 

Add to Wishlist
Categories: , Tag:

Description

NUCLEAR PHARMACY CONFERENCE (Saturday Only)

Saturday, October 17, 2026 

Therapy Protocols and Extravasations

8:00am-9:30am (1.5 CEUs)

Garcia Simon Clark, PharmD, MS, ANP, CCP, BCNP, Kindred Healthcare, Pharmacy Supervisor

Upon completion of this activity, participants will be able to: Review patient specific communication safety counseling points; Optimize therapy through dosage adjustments and side effect monitoring parameters; Review therapy protocols and patient specific factors; Explain extravasation management pertaining to radiopharmaceuticals.

UAN: 0675-0000-26-035-L01-P

 

Beyond Perfusion: Cardiac Imaging in Amyloidosis and Sarcoidosis 

9:30am-11:00am (1.5 CEUs)
Vesper Grantham, MEd, RT(N), CNMT, Chair, Medical Imaging and Radiation Sciences, Program Director, Nuclear Medicine

Upon completion of this activity, participants will be able to: Discuss the indications and appropriate use of nuclear imaging for the diagnosis and management of cardiac amyloidosis and cardiac sarcoidosis; Contrast the imaging techniques for SPECT/CT cardiac amyloidosis and PET/CT cardiac sarcoidosis; Describe and differentiate the clinical presentation for cardiac amyloidosis and cardiac sarcoidosis.

UAN: 0675-0000-26-036-L01-P

 

Radiochemical Purity, Calculations and Studies

11:15am-12:45pm (1.5 CEUs)

Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility

Upon completion of this activity, participants will be able to: Explain factors that affect radiochemical purity; Describe radionuclide impurity biodistribution; Perform calculations and sight studies with rigor.

UAN: 0675-0000-26-037-L01-P

 

Off Target; Radiopharmaceutical Medical Events and Misadventures

12:45pm-2:15pm (1.5 CEUs)

Nic Mastascusa, PharmD, BCNP, Clinical Associate Professor of Pharmacy Practice, Department of Pharmacy Practice, Radiopharmaceutical Programs, Sidney & Lois Eskenazi Hospital


Upon completion of this activity, participants will be able to: Define reportable medial events under 10 CFR 35 criteria; Identify hot spot failure points in dispensing and administration; Analyze cases from NRC reportable events to determine contributing factors; Apply NRC minimal criteria to determine if an event qualifies as a reportable event.

UAN: 0675-0000-26-038-L05-P

 

Related products